SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-277199
Filing Date
2023-11-14
Accepted
2023-11-14 17:15:01
Documents
13
Period of Report
2023-11-14
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d456170d8k.htm   iXBRL 8-K 27248
2 EX-99.1 d456170dex991.htm EX-99.1 271972
  Complete submission text file 0001193125-23-277199.txt   456999

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA trml-20231114.xsd EX-101.SCH 2845
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE trml-20231114_lab.xml EX-101.LAB 18738
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE trml-20231114_pre.xml EX-101.PRE 11704
7 EXTRACTED XBRL INSTANCE DOCUMENT d456170d8k_htm.xml XML 3467
Mailing Address 27 WEST 24TH STREET SUITE 702 NEW YORK NY 10010
Business Address 27 WEST 24TH STREET SUITE 702 NEW YORK NY 10010 646-481-9832
Tourmaline Bio, Inc. (Filer) CIK: 0001827506 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40384 | Film No.: 231407937
SIC: 2836 Biological Products, (No Diagnostic Substances)